VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans

BACKGROUND: Candida albicans, the most common human fungal pathogen, causes chronic mucosal infections in patients with inborn errors of IL-17 immunity that rely heavily on chronic, often lifelong, azole antifungal agents for treatment. However, a rise in azole resistance has predicated a need for d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Break, Timothy J, Desai, Jigar V, Natarajan, Mukil, Ferre, Elise M N, Henderson, Christina, Zelazny, Adrian M, Siebenlist, Ulrich, Hoekstra, William J, Schotzinger, Robert J, Garvey, Edward P, Lionakis, Michail S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890729/
https://ncbi.nlm.nih.gov/pubmed/29040636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx352
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars